United States · FDA National Drug Code directory
Rizatriptan Benzoate
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 67877-262_9fd3ccaa-ae93-475b-9591-5c4af70f51c5
- Product NDC
- 67877-262
- Form
- TABLET
- Composition / generic term
- Rizatriptan Benzoate
- Labeler
- Ascend Laboratories, LLC
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20120625
- Source listing expiry
- 20261231
Source-listed ingredients
- RIZATRIPTAN BENZOATE — 10 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 100 TABLET in 1 BOTTLE (67877-262-01) · 67877-262-01
- 500 TABLET in 1 BOTTLE (67877-262-05) · 67877-262-05
- 3 BLISTER PACK in 1 CARTON (67877-262-18) / 6 TABLET in 1 BLISTER PACK · 67877-262-18
- 2 BLISTER PACK in 1 CARTON (67877-262-25) / 6 TABLET in 1 BLISTER PACK · 67877-262-25
- 30 TABLET in 1 BOTTLE (67877-262-30) · 67877-262-30
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →